BIOLUMINESCENT ASSAY FOR GENE EXPRESSION ANALYSIS
用于基因表达分析的生物发光测定
基本信息
- 批准号:7480704
- 负责人:
- 金额:$ 36.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-30 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:Antibiotic ResistanceAntiviral AgentsAreaBiochemical ReactionBiologicalBiological AssayBiological ModelsBiological SciencesBioluminescenceBuffersCollaborationsComplementary DNAComputer softwareDNADNA Microarray ChipDNA Microarray formatDNA biosynthesisDetectionDevelopmentDiphosphatesEnd PointEquipmentFoundationsFutureGelGene ExpressionGenesGenetic TranscriptionGenomicsGenotypeGoalsHIV-1HumanIndividualKineticsLabelLettersLightLiteratureLiverLuciferasesManufacturer NameMeasurementMeasuresMethodologyMissionMonitorNational Center for Research ResourcesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of General Medical SciencesNucleic AcidsNucleotidesNumbersOligonucleotidesPerformancePharmaceutical PreparationsPhasePhotonsPolymerasePolymerase Chain ReactionProgress ReportsProtocols documentationPubMedPublicationsPublishingRNARNA replicationRadioactiveRangeReactionReagentReportingResearchReverse TranscriptionSamplingSeriesSignal TransductionSiteSolidSolutionsStaphylococcus aureusSulfate AdenylyltransferaseSystemTechniquesTechnologyTemperatureTennesseeTestingTimeUnited States National Institutes of HealthUniversitiesValidationVeterinary MedicineVisible RadiationWorkbaseclinical Diagnosisclinical applicationcollegecommercializationconceptcostcost effectivedesigndrug discoveryhigh throughput screeninginhibitor/antagonistinstrumentinstrumentationluciferinmicrobialnew technologynucleic acid detectionpolymerizationprogramsresearch and developmentresearch studytechnology development
项目摘要
DESCRIPTION (provided by applicant): The goal of this project is to develop a new highly sensitive and cost effective RNA Bioluminescent Assay (RT-qBLA) for high-throughput detection and quantification of RNA and DNA in biological samples. The assay implements the same detection concept known from pyrosequencing, yet expanding pyrosequencing methodology for highly sensitive and accurate quantification of RNA and DNA molecules. The proposed assay has unique sensitivity and dynamic range and is able to measure kinetics of RNA and DNA replication in the solution in real time without long and expensive sample amplification of the real time PCR. The RT-qBLA requires less expensive reagents and equipment than real time PCR and DNA microarrays and can be used in a various commercial assays in life sciences research, drug discovery, and clinical diagnosis.
描述(申请人提供):本项目的目标是开发一种新的高灵敏度和低成本的RNA生物发光分析方法(RT-qBLA),用于高通量检测和定量生物样品中的RNA和DNA。该分析实现了与焦磷酸测序相同的检测概念,但扩展了焦磷酸测序方法,以实现高灵敏度和准确的RNA和DNA分子定量。该方法具有独特的灵敏度和动态范围,能够实时测量RNA和DNA在溶液中的复制动力学,而不需要花费大量昂贵的样品进行实时聚合酶链式反应。与实时聚合酶链式反应和DNA微阵列相比,RT-qBLA需要更便宜的试剂和设备,可用于生命科学研究、药物发现和临床诊断的各种商业分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Val V. Golovlev其他文献
Val V. Golovlev的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Val V. Golovlev', 18)}}的其他基金
NOVEL ASSAY PLATFORM FOR ASESSING PROTEIN KINASE INHIBITORS
用于评估蛋白激酶抑制剂的新型检测平台
- 批准号:
7745795 - 财政年份:2009
- 资助金额:
$ 36.44万 - 项目类别:
BIOLUMINESCENT ASSAY FOR GENE EXPRESSION ANALYSIS
用于基因表达分析的生物发光测定
- 批准号:
7617864 - 财政年份:2006
- 资助金额:
$ 36.44万 - 项目类别:
Bioluminscence Assay for Gene Expression Analysis
用于基因表达分析的生物发光测定
- 批准号:
7219640 - 财政年份:2006
- 资助金额:
$ 36.44万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 36.44万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 36.44万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 36.44万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 36.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 36.44万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 36.44万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 36.44万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 36.44万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 36.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 36.44万 - 项目类别:














{{item.name}}会员




